MAWCM
CRBP icon

Mine & Arao Wealth Creation & Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Mine & Arao Wealth Creation & Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-33
Closed -$8K – 265
2020
Q2 		$8K Hold
33
– – 0.01% 191
2020
Q1 		$5K Hold
33
– – 0.01% 200
2019
Q4 		$5K Buy
+33
New +$4.88K ﹤0.01% 211

Other funds holding CRBP

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Mine & Arao Wealth Creation & Management's CRBP Position: Q3 2020 in Review

Mine & Arao Wealth Creation & Management sold out of Corbus Pharmaceuticals (CRBP) in Q3 2020, closing a stake of 33 shares — an estimated $8K sold.

Mine & Arao Wealth Creation & Management first reported a position in CRBP in Q4 2019 and held it in 3 quarters. The position peaked at $8K in Q2 2020. 122 funds tracked by Wall St. Rank hold CRBP as of Q3 2020.

  • Mine & Arao Wealth Creation & Management reported no remaining Corbus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Mine & Arao Wealth Creation & Management sold 33 Corbus Pharmaceuticals shares in Q3 2020, an estimated $8K.
  • Mine & Arao Wealth Creation & Management first reported a position in Corbus Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Mine & Arao Wealth Creation & Management's Corbus Pharmaceuticals position peaked at $8K in Q2 2020.
  • 122 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2020.

Based on Mine & Arao Wealth Creation & Management's 13F filing for Q3 2020, filed 13 Nov 2020.